Determining risk between Depo-Provera use and increased uterine bleeding in obese and overweight women

Journal of the American Board of Family Practice

Volumn 15, Issue 1, 2002, Pages 7-10

  Connor, Pamela D ^a   Tavernier, Laura A ^a   Thomas, Sheila M ^a   Gates, Diane ^a   Lytton, Sallie M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BODY MASS; COMORBIDITY; CONTRACEPTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT SATISFACTION; RISK ASSESSMENT; UTERUS BLEEDING;

ADOLESCENT; ADULT; BODY MASS INDEX; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MEDICAL RECORDS; MEDROXYPROGESTERONE 17-ACETATE; OBESITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UTERINE HEMORRHAGE;

EID: 0036157225     PISSN: 08938652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Harel Z, Biro FM, Kollar LM, Rauh JL. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health 1996;19:118-23.
2. Kaunitz AM. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Int J Fertil Womens Med 1998;43(2):73-83.
3. Keder LM, Rulin MC, Gruss J. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders. Am J Obstet Gynecol 1998;179(3 Pt 1)):583-5.
4. Fraser IS, Dennerstein GJ. Depo-Provera use in an Australian metropolitan practice. Med J Australia 1994;160:553-6.
5. Nutley T, Danson TR. Treatment of bleeding problems associated with progestin-only contraceptives: survey results. Adv Contracept 1997;13:419-28.
6. Hill DA. Gynecology case challenge: vaginal bleeding in a woman taking an injectable contraceptive. Medscape Womens Health 1998;3(1):4.
7. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health, National Heart, Lung, and Blood Institute. Available at http://www.nhlbi. nih.gov.
8. Mealformation and your body mass index. The calculation of your body mass index based on your weight and height. Available at: http://www.mealformation.com/bmassidx.htm.
9. Heart Information Network (1997, Jan). Most Americans are overweight (online). Available at: http://www.heartinfo.org/mosamfat197.htm Accessed 7 Nov 2000.
10. Heart Information Network (2000 Mar 14). Americans eating more, exercising less. Available at: http://www. heartinfo.org/reuters2000/t031410f.htm. Accessed 7 Nov 2000.
11. Schwallie PC, Assenzo JR. Contraceptive use-efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973;24:331-9.
12. Kaunitz AM. DMPA: a new contraceptive option. Contemp OB/GYN 1993;38:19-34.